Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valens International is a leading European manufacturer of innovative food supplements and functional ingredients, specializing in advanced delivery systems such as oral sprays and syrups. The company is globally recognized for its proprietary Q10Vital® technology, which significantly enhances the bioavailability of Coenzyme Q10 through a water-soluble formulation. Valens operates as both a branded product manufacturer and a contract development and manufacturing organization (CDMO), serving international markets with GMP-certified production facilities. Their portfolio primarily focuses on preventive health, including vitamin D, immunity, and cardiovascular support. The company distinguishes itself through a commitment to science, frequently conducting clinical studies on its finished products to validate efficacy and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valens International.